Delivery Order SPE2DB22D3501-SPE2DB25FWK51
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) with a ceiling value of $3,388.33. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varenicline 1 mg tablets (56-count units) with a contract ceiling value of $4,096.42. This is a firm fixed-price delivery order with no set-aside designation, completed competitively, and is scheduled for ultimate completion by September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varenicline 0.5 mg tablets (56-count units) under a firm fixed-price contract with a ceiling value of $5,061.75. The award, issued on May 22, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 23, 2025. This order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varenicline 1mg tablets (56-count packages) valued at $7,668.62, with completion scheduled for July 30, 2025. This competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued under a non-set-aside competitive process, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,432.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,316.60 to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packages) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical supply transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,996.74 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a quantity of 56 units. The contract was awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under the company's existing federal contract vehicle, with performance to be fulfilled at...
- The Defense Logistics Agency awarded a $1,827.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 56 tablets of Varenicline 1 mg on September 24, 2025, with completion expected by September 25, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The company, headquartered in...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWK51Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $2,360.02 and a firm fixed price structure. This is a non-set-aside competitively awarded contract with an ultimate completion date of July 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a small-value transaction within the company's broader pharmaceutical distribution portfolio supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical vendor to the Defense Logistics Agency, AmerisourceBergen supplies a extensive range of medications, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Varenicline order exemplifies the company's role in providing critical pharmaceutical products across multiple therapeutic domains to military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/15/25 |